Sort
15,273 grants matching “antimicrobial resistance”
NJDA Animal Health Diagnostic Laboratory and FDA CVM VetLIRN Program Co-operative Agreement to Safeguard Animal and Human Health
$22,000Amar Patil · New Jersey State Departmentr/Agriculture · U18 · FY2020 · FD
ANHYDROMURAMIC ACID KINASE
$21,824Catherine L Allen · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2009 · RR
TASK A33: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY
$21,670Thomas Patterson · University Of Texas Hlth Science Center · N01 · FY2019 · AI
Task X12: Development of a Gonorrhea Vaccine
$21,423James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
Identification and inhibition of hydrolases in Mycobacterium tuberculosis
$21,361Hiren Vijay Patel · State University New York Stony Brook · F30 · FY2016 · AI
Polyphenolic inhibitors of S. Mutans glucosyltransferases to fight dental caries
$21,329Bhavitavya Nijampatnam · University Of Alabama At Birmingham · F31 · FY2017 · DE
Task C04: Stability testing of an antiparasitic therapeutic
$21,174Mary Bastida · Sri International · N01 · FY2021 · AI
Task A15: In vitro screening for antibacterial activity against public health disease pathogens
$21,044Thomas Patterson · University Of Texas Hlth Science Center · N01 · FY2022 · AI
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): POPULATION PHARMACOKINETICS STUDY
$21,000Patricia Winokur · University Of Iowa · N01 · FY2019 · AI
Monitoring antimicrobial resistance among veterinary pathogens at Iowa State University Veterinary Diagnostic Laboratory: A Vet-LIRN AMR Surveillance Project
$20,800Orhan Sahin · Iowa State University · U18 · FY2022 · FD
DISSERTATION RESEARCH: Inter-strain variation and evolution of resistance to phytochemicals in the bumblebee trypanosome parasite, Crithidia bombi
$20,735Lynn S Adler · University Of Massachusetts Amherst · · FY2015 · BIO
Impact of commensal Corynebacterium species on pathogen colonization and microbiota composition
$20,558Katherine Paige Lemon · Ada Forsyth Institute, Inc. · R01 · FY2019 · GM
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases
$20,375John McLeod Griffiss · Icon Government And Public Health Solutions, Inc. · N01 · FY2016 · AI
The impact of dietary manganese on the immune response during Staphylococcus aureus infection of the heart
$20,289Andrew J Monteith · Vanderbilt University Medical Center · F32 · FY2020 · HL
Diversity Supplement to Immune Evasion Mechanisms of Mycoplasma genitalium V
$20,269Gwendolyn Wood · University Of Washington · R21 · FY2021 · AI
Diversity Supplement to Immune Evasion Mechanisms of Mycoplasma genitalium Z
$20,269Gwendolyn Wood · University Of Washington · R21 · FY2021 · AI
Elucidating Rgg-mediated quorum sensing networks in Streptococcus pneumoniae and their contributions in pathogenesis
$20,207Kayleigh Tovar · University Of Illinois At Chicago · F31 · FY2020 · AI
Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria
$20,000Patrick R Murray · Clinical Center · Z01 · FY2007 · CL
Creating natural product diversity via the fabrication of a hybrid fatty acid-nonribosomal peptide synthetase
$19,865Joshua Catungal Corpuz · University Of California, San Diego · F31 · FY2022 · GM
PHASE 1 CLINICAL TRIALS UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: EVALUATION OF THERAPEUTICS FOR NEISSERIA GONORRHOEAE
$19,597David Shumway · Dynport Vaccine Company, Llc · N01 · FY2019 · AI
DETERMINE EFFECT OF ANTIMICROBIAL OLIGOMERS ON BACTERIAL AND EUKARYOTIC CELLS
$19,596Annelise Barron · University Of California, San Francisco · P41 · FY2011 · RR
Probing the impact of polymicrobial interactions on the virulence of an oral pathogen
$19,578Gina Lewin · Georgia Institute Of Technology · F32 · FY2017 · DE
Novel mycobacterial translocase I inhibitors - a new class of anti-TB drugs
$19,372Venkata M Reddy · Sequella, Inc. · R44 · FY2009 · AI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections
$19,288Huizhou Fan · Rbhs-Robert Wood Johnson Medical School · R33 · FY2011 · AI
A plasma proteomic diagnostic for melioidosis
$19,278Timothy Eoin West · University Of Washington · R21 · FY2025 · AI